Wang Bing, Song Yang, Chen Yan, Wang En-Sheng, Zheng Dan, Qu Fan, Zhou Jian-Hong
Women's Hospital School of Medicine Zhejiang University Hangzhou 310006, China ; The Second Hospital of Jia Xing Jia Xing 314000, China.
Women's Hospital School of Medicine Zhejiang University Hangzhou 310006, China.
Int J Clin Exp Med. 2015 Feb 15;8(2):2417-22. eCollection 2015.
The sudden drop in estrogen in post-menopausal women can lead to osteoporosis. About one in three women aged more than 50 years experienced an osteoporotic fracture. The aim of this study is to explore function of follicle-stimulating hormone (FSH) in bone metabolism and osteoporosis in menopausal transition women. 164 cases of women in menopausal transition were included, and which were divided into three groups, including < 40 years group, 40-50 years group and > 50 years group. All of patients must with empty stomach, and 5 ml blood was collected from median cubital vein between second day to ninth day in menstruation period. Examination of FSH and C-terminal cross-linked telopetides of type I collagen (CTx) was performed by using ECLIA assay. The results indicated that CTx levels were distinguished among the different aged group, with the increasing level following with the increased age. FSH level in both of < 40 years and 40-50 years old women were positively correlated with CTx level (P < 0.05). The spearman rank correlation analysis results also showed that there were no significant correlation between CTx level and FSH level in > 50 years old women. There were significant differences for the CTx level between 0-40 mIU/ml group and > 40 40 mIU/ml group in all of the three ages group (P < 0.05). In conclusion, it's clinically significant for the combining examination of FSH and CTx in menopausal transition women, which could observe the bone metabolize changes quickly and sensitively, and prevent or therapy the osteoporosis in a further step.
绝经后女性雌激素的突然下降会导致骨质疏松症。50岁以上的女性中约有三分之一经历过骨质疏松性骨折。本研究的目的是探讨促卵泡激素(FSH)在围绝经期女性骨代谢和骨质疏松症中的作用。纳入164例围绝经期女性,分为三组,即<40岁组、40 - 50岁组和>50岁组。所有患者均需空腹,在月经期的第二天至第九天从肘正中静脉采集5ml血液。采用电化学发光免疫分析(ECLIA)法检测FSH和I型胶原C末端交联肽(CTx)。结果表明,不同年龄组的CTx水平存在差异,且随着年龄的增加而升高。<40岁和40 - 50岁女性的FSH水平均与CTx水平呈正相关(P < 0.05)。Spearman等级相关分析结果还显示,>50岁女性的CTx水平与FSH水平之间无显著相关性。在所有三个年龄组中,0 - 40 mIU/ml组和>40 mIU/ml组的CTx水平存在显著差异(P < 0.05)。总之,围绝经期女性联合检测FSH和CTx具有临床意义,可快速、灵敏地观察骨代谢变化,并进一步预防或治疗骨质疏松症。